|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | sAPP Total (Highly Sensitive) ELISA Assay | a-Synuclein ELISA Assay | Endothelial Lipase (EL) C-Terminal ELISA | Influenza Virus A IgG ELISA | Taenia Solium IgG ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27731 | 27740 | 27263 | IB79878 | IB79825 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of human total sAPP in serum, EDTA plasma, cerebrospinal fluid and cell culture supernatant as a total amount. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination Human a-Synuclein in serum, EDTA plasma, CSF and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of Endothelial Lipase (EL) C-Terminal in human serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | The Influenza Virus A IgG ELISA is intended for the qualitative determination of IgG class antibodies against Influenza Virus A in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | Enzyme-linked immunosorbent assay (ELISA) for the determination of IgG class antibodies against Taenia solium in human serum or plasma (citrate). For research use only, not for use in diagnostic procedures. |
| Detection Target | Bordetella pertussis IgG | Histamine | Noradrenaline | Sex Hormone Binding Globulin (SHBG) | Estradiol, 17 Beta |
| Sample Type | Serum, Blood Plasma | Blood Plasma, Urine | Multiple | Human Serum | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0.39 to 25 ng/mL | 0.16 to 10.00 ng/mL | 0 / 0.13 to 8 ng/mL | A cut-off control is used for the interpretation of results. | Inquire |
| Sensitivity | 98.31% (95% confidence interval: 90.91% - 99.96%) | Plasma: 0.12 ng/mL; Urine: 0.30 ng/mL. | 0.1 ng/mL x Correction Factor (please see protocol) | 0.1 nmol/L | Inquire |
| Assay Time | Overnight + 1 hr (incubation) | Overnight + 1 hr 30 min. (incubation) | Overnight + 30 min. (incubation) | 1 hr 45 mins (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |